Intellectual Property India Publishes Patent Application for Rnai Agents For Inhibiting Expression Of Activin Receptor-Like Kinase 7 (alk7), Compositions Thereof, And Methods Of Use

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617076216 A) filed by Arrowhead Pharmaceuticals, Inc. on June 19, 2026, for Rnai Agents For Inhibiting Expression Of Activin Receptor-Like Kinase 7 (alk7), Compositions Thereof, And Methods Of Use.

Inventors include Ngai, Michelle; Majewski, Mark; Ding, Zhi-Ming; Glebocka, Agnieszka; Pei, Tao; Hamilton, James Number; and Shekhtman, Grigoriy.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of an Activin Receptor-Like Kinase 7 (ALK7) gene. The ALK7 RNAi agents and RNAi agent conjugates disclosed herein inhib...